Skip to main content
Enhabit, Inc. (EHAB)
NYSE: EHAB · IEX Real-Time Price · USD
8.76
+0.01 (0.11%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Enhabit Revenue

Enhabit had revenue of $1.04B in the twelve months ending March 31, 2024, down -1.72% year-over-year. Revenue in the quarter ending March 31, 2024 was $262.40M, a -1.02% decrease year-over-year. In the year 2023, Enhabit had annual revenue of $1.05B, a decrease of -2.32%.

Revenue (ttm)
$1.04B
Revenue Growth
-1.72%
P/S Ratio
0.42
Revenue / Employee
$96,630
Employees
10,800
Market Cap
439.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.05B-24.80M-2.32%
Dec 31, 20221.07B-35.50M-3.21%
Dec 31, 20211.11B28.40M2.63%
Dec 31, 20201.08B-13.80M-1.26%
Dec 31, 20191.09B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 187.32M
Avid Bioservices 136.74M
Voyager Therapeutics 119.04M
Alector 96.41M
EyePoint Pharmaceuticals 50.02M
OmniAb 21.05M
Taysha Gene Therapies 14.16M
Revenue Rankings

EHAB News

More News